Post

First patient enrolled in pulmonary hypertension reduction device study

Paris-based Gradient Denervation Technologies has performed the first procedure in its first-in-human clinical study for a pulmonary hypertension device.   The …

Innovent and Merck to carry out cancer combination therapy trial

Innovent Biologics and Merck have entered a clinical trial collaboration and supply agreement for the combination therapy of IBI351 (GFH925) …

YS Biopharma receives approval for vaccine trial in Philippines

The Food and Drug Administration (FDA) of the Philippines has given approval to biopharmaceutical firm YS Biopharma to begin a …

Bluejay Therapeutics makes progress in Hepatitis B and D Trials

Bluejay Therapeutics has reported the successful completion of a Phase Ia trial and enrolment of the initial Phase Ib cohorts …

AstraZeneca abandons inflammatory bowel disease drug

AstraZeneca’s brazikumab inflammatory bowel disease (IBD) development programme has been discontinued due to trial delays. Brazikumab, an anti-IL-23 monoclonal antibody, was …